carvedilol has been researched along with Cardiac Death in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study assessed the effects of combination therapy with simvastatin and carvedilol on clinical outcome in patients with left ventricular (LV) dysfunction after acute myocardial infarction (AMI)." | 7.73 | Effect of combination therapy with simvastatin and carvedilol in patients with left ventricular dysfunction complicated with acute myocardial infarction who underwent percutaneous coronary intervention. ( Ahn, Y; Cho, JG; Hong, SN; Hong, YJ; Hwang, SH; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Lee, SR; Park, HW; Park, JC; Yun, NS, 2006) |
| "This study assessed the effects of combination therapy with simvastatin and carvedilol on clinical outcome in patients with left ventricular (LV) dysfunction after acute myocardial infarction (AMI)." | 3.73 | Effect of combination therapy with simvastatin and carvedilol in patients with left ventricular dysfunction complicated with acute myocardial infarction who underwent percutaneous coronary intervention. ( Ahn, Y; Cho, JG; Hong, SN; Hong, YJ; Hwang, SH; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Lee, SR; Park, HW; Park, JC; Yun, NS, 2006) |
| "Crude incidence of cardiac death and/or recurrent myocardial infarction (cardiac death/MI) tended to be higher in the β group (7." | 1.39 | β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction. ( Bao, B; Fujiwara, H; Furukawa, Y; Hayano, M; Iwabuchi, M; Kadota, K; Kato, Y; Kimura, T; Kita, T; Mitsudo, K; Morimoto, T; Nakagawa, Y; Natsuaki, M; Nobuyoshi, M; Ozasa, N; Shiomi, H; Shizuta, S; Tada, T; Tazaki, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, B | 1 |
| Ozasa, N | 1 |
| Morimoto, T | 1 |
| Furukawa, Y | 1 |
| Nakagawa, Y | 1 |
| Kadota, K | 1 |
| Iwabuchi, M | 1 |
| Shizuta, S | 1 |
| Shiomi, H | 1 |
| Tada, T | 1 |
| Tazaki, J | 1 |
| Kato, Y | 1 |
| Hayano, M | 1 |
| Natsuaki, M | 1 |
| Fujiwara, H | 1 |
| Mitsudo, K | 1 |
| Nobuyoshi, M | 1 |
| Kita, T | 1 |
| Kimura, T | 1 |
| Hong, YJ | 1 |
| Jeong, MH | 1 |
| Hwang, SH | 1 |
| Yun, NS | 1 |
| Lee, SR | 1 |
| Hong, SN | 1 |
| Kim, KH | 1 |
| Park, HW | 1 |
| Kim, JH | 1 |
| Ahn, Y | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
2 other studies available for carvedilol and Cardiac Death
| Article | Year |
|---|---|
β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Carbazoles; Carvedilol; Combined Modality Ther | 2013 |
Effect of combination therapy with simvastatin and carvedilol in patients with left ventricular dysfunction complicated with acute myocardial infarction who underwent percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Carbazoles; Carvedilol; Death; Disease-Free Survival; Drug Eva | 2006 |